• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Microbot Medical Inc. - Common Stock (NQ:MBOT)

2.300 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,648
Open 2.300
Bid (Size) 2.330 (1,300)
Ask (Size) 2.350 (300)
Prev. Close 2.300
Today's Range 2.300 - 2.300
52wk Range 1.600 - 4.670
Shares Outstanding 67,158,044
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
April 14, 2026
The presentation will be webcast live on April 15 at 10:15 a.m. ET. Continued Engagement with Healthcare Institutions Reflects Rising Momentum 
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
April 13, 2026
Successful Execution of the Limited Market Release (LMR) Includes Adoption by Globally Recognized Healthcare Systems in the U.S. Market and Demonstrates Broad Market Scalability in Key Endovascular... 
From Microbot Medical Inc.
Via GlobeNewswire

Performance

YTD
+9.0%
+9.0%
1 Month
-8.7%
-8.7%
3 Month
+10.6%
+10.6%
6 Month
-17.9%
-17.9%
1 Year
+3.1%
+3.1%

More News

Read More
News headline image
Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
March 26, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
March 24, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Participate at the 38th Annual Roth Conference
March 17, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
March 10, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
March 04, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company ↗
March 03, 2026
Via Stocktwits
News headline image
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
March 03, 2026
From Microbot Medical Inc.
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
February 24, 2026
Via Chartmill
News headline image
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
February 24, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
February 19, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
February 12, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
February 05, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
January 12, 2026
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
November 26, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
November 05, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
October 16, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
October 14, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
October 07, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
October 01, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
September 23, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
September 16, 2025
From Microbot Medical Inc.
Via GlobeNewswire
News headline image
Monday's session: gap up and gap down stocks ↗
September 15, 2025
Via Chartmill
News headline image
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
September 15, 2025
From Microbot Medical Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Microbot Medical Inc. - Common Stock publicly traded?
Yes, Microbot Medical Inc. - Common Stock is publicly traded.
What exchange does Microbot Medical Inc. - Common Stock trade on?
Microbot Medical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Microbot Medical Inc. - Common Stock?
The ticker symbol for Microbot Medical Inc. - Common Stock is MBOT on the Nasdaq Stock Market
What is the current price of Microbot Medical Inc. - Common Stock?
The current price of Microbot Medical Inc. - Common Stock is 2.300
When was Microbot Medical Inc. - Common Stock last traded?
The last trade of Microbot Medical Inc. - Common Stock was at 04/20/26 04:00 PM ET
What is the market capitalization of Microbot Medical Inc. - Common Stock?
The market capitalization of Microbot Medical Inc. - Common Stock is 154.46M
How many shares of Microbot Medical Inc. - Common Stock are outstanding?
Microbot Medical Inc. - Common Stock has 154M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap